On the basis of our assessments of internal and external validity, the precision of the effect estimates, and the consistency of the results from various subgroup analyses and extensive sensitivity analyses, we concluded that MALAT1 expression status is not associated with prognostic outcomes of CRC patients. The gene discussed is MALAT1; the disease is colorectal carcinoma.